GGrantIndex
← Leaderboards

David Kc Cooper

Massachusetts General Hospital

$22,744,194
Attributed
$24,316,357
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.2M · FY200524
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$50,665,836 · 12

By mechanism

U19$40,674,935 · 7
U01$5,854,738 · 2
P01$3,731,315 · 2
R21$404,848 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Family Suidae

Research focus

Family SuidaeOrgan TransplantationOrganXenograft ProcedurePrimatesNonhuman PrimatePapioGenetic EngineeringImmune ResponseCoagulation ProcessHeart TransplantationKidneySuccessGraft SurvivalImmunologicsProgramsRegimenFundingClinical TrialsGenetic ManipulationKidney TransplantationLifeHeartPlay

Grant awards (71)

Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function$1,835,262
U19 · FY2024 · AI · contact PI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies$1,576,760
U19 · FY2024 · AI · contact PI
Administrative Core$79,120
U19 · FY2024 · AI · contact PI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies$1,576,760
U19 · FY2023 · AI · contact PI
Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function$563,572
U19 · FY2023 · AI · contact PI
Administrative Core$160,714
U19 · FY2023 · AI · contact PI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies$1,593,760
U19 · FY2022 · AI · contact PI
Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function$841,220
U19 · FY2022 · AI · contact PI
Administrative Core$60,595
U19 · FY2022 · AI · contact PI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies$1,497,588
U19 · FY2021 · AI · contact PI
Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function$664,334
U19 · FY2021 · AI · contact PI
Administrative Core$62,685
U19 · FY2021 · AI · contact PI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies$1,497,591
U19 · FY2020 · AI · contact PI
Administrative Core$299,519
U19 · FY2020 · AI · contact PI
Genetically-engineered pig kidney transplantation in baboons: reducing the adaptive immune response and monitoring graft function$299,518
U19 · FY2020 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$2,429,398
U19 · FY2019 · AI · contact PI
Administrative$788,901
U19 · FY2019 · AI · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$736,372
U19 · FY2019 · AI · contact PI
Administrative$112,125
U19 · FY2019 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$112,125
U19 · FY2019 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$2,429,398
U19 · FY2018 · AI · contact PI
Administrative$801,025
U19 · FY2018 · AI · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$736,372
U19 · FY2018 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$2,429,398
U19 · FY2017 · AI · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$1,016,749
U19 · FY2017 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$608,159
P01 · FY2017 · HL · contact PI
Administrative$116,108
U19 · FY2017 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$1,325,534
U19 · FY2016 · AI · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$763,645
U19 · FY2016 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$529,860
P01 · FY2016 · HL · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$486,610
U19 · FY2016 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$409,310
U19 · FY2016 · AI · contact PI
Administrative$71,736
U19 · FY2016 · AI · contact PI
Administrative$71,634
U19 · FY2016 · AI · contact PI
Genetically-engineered Pig Organ Transplantation into Non-human Primates$1,766,506
U19 · FY2015 · AI · contact PI
Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammation$605,540
U19 · FY2015 · AI · contact PI
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys$582,132
U01 · FY2015 · AI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$342,789
P01 · FY2015 · HL · contact PI
Administrative$56,885
U19 · FY2015 · AI · contact PI
Genetically-engineered pig organ transplantation into nonhuman primates$1,594,492
U19 · FY2014 · AI · contact PI
Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons$627,664
U19 · FY2014 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$344,353
P01 · FY2014 · HL · contact PI
Administrative Core$42,386
U19 · FY2014 · AI · contact PI
Genetically-engineered pig organ transplantation into nonhuman primates$1,438,261
U19 · FY2013 · AI · contact PI
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys$605,488
U01 · FY2013 · AI
Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons$567,587
U19 · FY2013 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$334,822
P01 · FY2013 · HL · contact PI
Administrative Core$42,270
U19 · FY2013 · AI · contact PI
Genetically-engineered pig organ transplantation into nonhuman primates$1,530,066
U19 · FY2012 · AI · contact PI
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys$644,136
U01 · FY2012 · AI
Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons$534,647
U19 · FY2012 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$321,964
P01 · FY2012 · HL · contact PI
Administrative Core$46,453
U19 · FY2012 · AI · contact PI
Genetically-engineered pig organ transplantation into nonhuman primates$1,544,173
U19 · FY2011 · AI · contact PI
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys$646,234
U01 · FY2011 · AI
Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons$519,880
U19 · FY2011 · AI · contact PI
Therapeutic assessment of synthetic heparin sulfates in transplantation models$360,645
P01 · FY2011 · HL · contact PI
Administrative Core$86,759
U19 · FY2011 · AI · contact PI
Genetically-engineered pig organ transplantation into nonhuman primates$1,598,359
U19 · FY2010 · AI · contact PI
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys$666,337
U01 · FY2010 · AI
Effect of Genetic Modifications on Pig Heart and Kidney Graft Survival in Baboons$531,166
U19 · FY2010 · AI · contact PI
Administrative Core$96,403
U19 · FY2010 · AI · contact PI
Thromboregulation to Prevent Thrombotic Microangiopathy$666,460
U01 · FY2008 · AI · contact PI
Tolerance to Carbohydrate Antigens in Transplantation$182,098
R21 · FY2008 · AI · contact PI
Thromboregulation to Prevent Thrombotic Microangiopathy$661,727
U01 · FY2007 · AI · contact PI
Tolerance to Carbohydrate Antigens in Transplantation$222,750
R21 · FY2007 · AI · contact PI
Thromboregulation to Prevent Thrombotic Microangiopathy$664,163
U01 · FY2006 · AI · contact PI
Thromboregulation to Prevent Thrombotic Microangiopathy$718,061
U01 · FY2005 · AI
B CELL TOLERANCE TO GAL-ALPHA 1-3 GAL EPITOPE$296,241
P01 · FY2002 · AI
B CELL TOLERANCE TO GAL-ALPHA 1-3 GAL EPITOPE$296,241
P01 · FY2001 · AI
B CELL TOLERANCE TO GAL-ALPHA 1-3 GAL EPITOPE$296,241
P01 · FY2000 · AI